CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-10 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $91.70 | $57K | 40,033.91 |
| 2026-07-10 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 4,952 | ||
| 2026-07-09 | Mistras Theodora CVP, Chief Financial Officer | Grant or award | +87,595 | 87,595 | ||
| 2026-07-09 | Mistras Theodora CVP, Chief Financial Officer | Grant or award | +12,325 | 99,920 | ||
| 2026-07-09 | Mistras Theodora CVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Acquire) | +61,800 | 61,800 | ||
| 2026-07-09 | Mistras Theodora CVP, Chief Financial Officer | Grant or award · Performance Rights | +12,325 | 12,325 | ||
| 2026-07-07 | Lippis Daniel J. CVP, TAVR | Shares withheld for taxes | −377 | $95.18 | $36K | 40,033.91 |
| 2026-06-30 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 41,029.91 |
| 2026-06-30 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $91.40 | $57K | 40,410.91 |
| 2026-06-30 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 5,571 | ||
| 2026-06-17 | Zovighian Bernard J CEO | Sale 10b5-1 | −523 | $87.92 | $46K | 11,516.55 |
| 2026-05-29 | Dahl Andrew M. SVP, Corporate Controller | Sale | −567.53 | $86.08 | $49K | 15,334.09 |
| 2026-05-27 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | −23,145 | $86.42 | $2.0M | 98,611 |
| 2026-05-22 | Chopra Daveen CVP, TMTT & Surgical | Sale | −1,500 | $84.60 | $127K | 44,324 |
| 2026-05-18 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +620 | $72.68 | $45K | 41,030.91 |
| 2026-05-18 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −620 | $81.14 | $50K | 40,410.91 |
| 2026-05-18 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −620 | 6,190 | ||
| 2026-05-15 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | −9,968 | $82.07 | $818K | 22,798.25 |
| 2026-05-15 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | −8,000 | $81.82 | $655K | 30,969.58 |
| 2026-05-12 | Zovighian Bernard J CEO | Gift 10b5-1 | −26,640 | 99,164.65 |
Page 3 of 13 · 249 trades